Metraipolis › archive › dc_b341b4a0ba48

Gut microbiome disparities reflect type 2 diabetes progression and medication status — Europe PMC PMID:41858899

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41858899
DOI
10.1016/j.isci.2026.115156
License (as archived)
solo-consultazione
Archived
2026-11-05T10:08:47.652Z
SHA-256 of the archived text
b3bb8de038e9c74dc2f52cd5891703371a2b75f8a90b462aa0414796809d2c50
Stable URL of this page
https://metraipolis.com/documento/dc_b341b4a0ba48

How to cite

Gut microbiome disparities reflect type 2 diabetes progression and medication status — Europe PMC PMID:41858899 — Europe PMC (en), https://europepmc.org/article/MED/41858899 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b341b4a0ba48 (Metraipolis archive dc_b341b4a0ba48, sha256 b3bb8de038e9c74dc2f52cd5891703371a2b75f8a90b462aa0414796809d2c50)
BibTeX
@misc{dcb341b4a0ba48,
  title = {Gut microbiome disparities reflect type 2 diabetes progression and medication status — Europe PMC PMID:41858899},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41858899},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b341b4a0ba48; sha256 b3bb8de038e9c74dc2f52cd5891703371a2b75f8a90b462aa0414796809d2c50},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41858899. Agents can read the archived copy with the MCP tool read_document.